BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment.

Authors:
Mokhtari M; Khoshbakht S; Akbari ME; Moravveji SS.

Journal:
BMC Med Genomics

Publication Year: 2023

DOI:
10.1186/s12920-023-01745-y

PMCID:
PMC10717810

PMID:
38087279

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Med Genomics

Abbreviation: BMC Med Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential 'culprit' fo…
Thomford NE; Abraham SA; Nyarko SB and 1 more (2024) - Transparency Score: 4/6
A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP famil…
Fu D; Zhang X; Zhou Y and 1 more (2024) - Transparency Score: 4/6
A systematic analysis of deep learning in genomics and histopathology for precision oncology.
Unger M; Kather JN. (2024) - Transparency Score: 3/6
Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cance…
Guo L; Cheng H; Liu J and 6 more (2024) - Transparency Score: 3/6
Behavioral variant frontotemporal dementia associated with GRN and ErbB4 gene mutations: a case rep…
Cai Y; Peng Z; He Q and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing InterestsThe authors declare no competing interests. Competing Interests The authors declare no competing interests."

Evidence found in paper:

"Funding The authors did not receive support from any organization for the submitted work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025